Oncology

We have diverse and measurable experience across the full range of oncology drug discovery programs.

Our deep therapeutic expertise in oncology covers the full range of relevant pathways, from targeted therapies to novel and emerging therapies.

We have extensive experience across the full range of oncology drug discovery programs. Our research service capabilities extend from preclinical and translational science to clinical development.

With our repertoire of different in vitro as well as in vivo models we drive deeply into the biology of our oncology programs to unravel molecular drivers of efficacy.

Through our long-standing experience with different drug targets we know how to establish and implement novel mechanistic cellular assays into the lead optimization screening tree.   

Our expertise comprise:

  • Oncogenic signaling pathways
  • Immuno-Oncology
  • Epigenetics
  • Tumor stem cells
  • Hormone-dependencies
  • Metabolism
  • Cellular stress / Hypoxia
  • Angiogenesis
  • Metastasis
  • Antibody Drug Conjugates